BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
about
Adhesion GPCRs in Tumorigenesis.Integrated Analysis of DNA Methylation and mRNA Expression Profiles Data to Identify Key Genes in Lung Adenocarcinoma.Cardiothoracic manifestations of neuroendocrine tumours.Gene polymorphisms are associated with clinical outcome in Chinese resected laryngeal carcinoma patientsRecent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.Adhesion GPCR Function in Pulmonary Development and Disease.The impact of immunohistochemistry on the classification of lung tumors.CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.An investigation into the potential role of brain angiogenesis inhibitor protein 3 (BAI3) in the tumorigenesis of small-cell carcinoma: a review of the surrounding literature.Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Update on large cell neuroendocrine carcinoma.CDX2 Stimulates the Proliferation of Porcine Intestinal Epithelial Cells by Activating the mTORC1 and Wnt/β-Catenin Signaling Pathways.Molecular alterations of neuroendocrine tumours of the lung.
P2860
Q33558191-3D3817EB-0D0A-440E-A9FD-AEA0760486C1Q36127680-7C466CB0-D0EB-4A47-9562-ECCB8EB48A30Q36839240-1617DB32-0EF6-43B9-854C-3E5C656FB3A0Q37687685-A774F5CA-5607-44F2-8B82-0FA3931ED8C7Q38364517-C2496D8D-3178-4AED-A09F-F87451D1AAB9Q38731913-A70A5DBA-8124-47A0-BE20-F28A67A0737FQ38822314-0B0F1B8D-567C-4A8A-9D40-AC4732FA3824Q38844086-FEEBD8DB-A6EC-493A-9B16-C45D6352A3E3Q39325922-515B607B-1B5C-4263-BF31-C5B7344FE559Q39934413-6F6ACD49-6688-4F52-A32E-66326B7F8CF9Q46316777-59D4FA86-7BE8-472C-A655-0E460018EC2BQ47130703-2783D959-DE67-4DDC-912D-82223E7D8083Q47312955-D25DA1AE-C87D-4AFD-AD0E-C4DA1E0C76DA
P2860
BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@ast
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@en
type
label
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@ast
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@en
prefLabel
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@ast
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@en
P2093
P2860
P50
P356
P1433
P1476
BAI3, CDX2 and VIL1: a panel o ...... euroendocrine lung carcinomas.
@en
P2093
Andrew G Nicholson
Danielle Peat
David R J Snead
Helen Brown
Irshad Soomro
John R Gosney
Keith M Kerr
Lesley A Ward
Muhammad F Bari
P2860
P304
P356
10.1111/HIS.12278
P577
2013-11-25T00:00:00Z